Psychedelics
October 1, 2026
Diego Borbón
In April 2025, New Mexico enacted the Medical Psilocybin Act, establishing the first legislated statewide medical psilocybin program and becoming the third state to authorize supervised psilocybin use. The Act directs the New Mexico Department of Health to build a regulated system where licensed clinicians provide psilocybin to qualified patients in approved settings for treatment-resistant...
Psychedelics
October 1, 2026
Benjamin R. Lewis, Eric L Garland, Zach Schwartz et al.
Background Psychedelic-assisted psychotherapy (PAP) has demonstrated great promise for a variety of mental health problems. Many clinicians and researchers who are engaged in providing PAP report personal experiences with psychedelics; these experiences are often positive. Still, there are ongoing questions regarding the relevance of therapists personal experience with psychedelic drugs for the...
Zenodo (CERN European Organization for Nuclear Research)
October 1, 2026
ROY Partha Partha
preprint
Whether current or near-future artificial intelligence systems possess phenomenal consciousness or sentience remains scientifically and philosophically unresolved, a fact openly acknowledged even by the industry laboratories that build these systems. This paper argues that this very uncertainty, far from licensing reduced ethical scrutiny, obligates greater scrutiny of AI systems deployed to...
Frontiers in Psychiatry
October 1, 2026
Matthew M. Kinney, Zackary L. Bowers
Ketamine has progressed from solely being an anesthetic agent to a drug of rising clinical and research interest due to its distinctive pharmacological properties. Its dissociative properties and rapid-acting antidepressant effects have made it a prominent area of investigation across many medical and psychiatric applications. This systematic review examines ketamine’s history, mechanisms of...
PLOS digital health
October 2026
Tom C Gordon, Andrew H Kemp, Josh Hope-Bell et al.
To synthesise the efficacy of digital third-wave process-based interventions (e.g., ACT, Mindfulness, Compassion) for improving wellbeing and ameliorating mental health symptoms in adults. A prospectively registered systematic review (OSF: 10.17605/OSF.IO/5RMU2) and random-effects meta-analysis of randomised controlled trials (RCTs) was conducted across six databases through January 2026....
Journal of Marital and Family Therapy
October 1, 2026
Ricardo S. S. Durães, Zila Elizabeth Pulache Vargas, Ana Cristina Garcia Dias et al.
ABSTRACT Psychosocial distress can exacerbate marital conflict, maladjustment, and mental health vulnerability. This pilot randomized clinical trial examined cognitive‐behavioral couple therapy (CBCT) integrated with mindfulness in low‐income Brazilian couples (per‐capita household income up to one minimum wage). Thirty‐four participants (17 heterosexual couples) were randomized (independent...
PsyArXiv Preprints
September 30, 2026
preprint
Objectives: To examine concurrent associations among cognitive-affective factors associated with psychological distress in young adults. Methods: Cross-sectional structural equation modelling was conducted in a community sample of 841 young adults aged 18 to 30 years. Psychological distress was specified as a latent factor indicated by depressive symptoms (PHQ-9), anxious symptoms (GAD-7), and...
International Journal of Academic Excellence and Research
September 30, 2026
S Venkatesan, D Rajendran
The growing incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) among night-shift IT professionals is posing as a major occupational health issue since shift work, sedentary lifestyle, psychosocial stress, lack of sleep, and disrupted circadian rhythms can lead to metabolism problems and fatty liver. Even though there is a possibility to cure NAFLD by adopting lifestyle changes, the...
Intemed International Journal of Research in Integrated Medical Sciences
September 30, 2026
Suhas More, Pankaj Kakde, Namita Gaikwad
Mental health and psychosomatic disorders are increasingly recognized as important contributors to morbidity and impaired quality of life. Anxiety, depressive symptoms, chronic stress, sleep disturbances and stress- related somatic complaints are associated with alterations in emotional regulation, autonomic function, neuroendocrine activity and cognitive processing. Ayurveda gives considerable...
Journal of Addictive Diseases
September 30, 2026
Rocco Miazzi, Clara Cestonaro, Claudio Terranova
BACKGROUND Adolescence represents a vulnerable developmental period during which cannabis exposure may be associated with psychological, neuropsychological, and neurobiological alterations. OBJECTIVE This structured review examines the psychological and neuropsychological effects associated with cannabis use during adolescence, focusing exclusively on human studies. METHODS A structured...